Spine Chronicle Japan
世界の高齢者の脊椎圧迫骨折を治療するための新たなインプラントと手術を実現します。
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Investors
DDiamond Medino Capital
- HHokuriku Startup Community Investment Limited Partnership
- KKumi Sakurai
LLifetime Ventures
PPremo Partners
QQR Investment
XXVC
- YYoshiro Yonezawa
Similar Health and bio companies
VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
PPhrontline Biopharma$40M Series A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/spine-chronicle-japan (get a free API key).